Recent Publications

January | February


Berry JL, Zhu W, Tang YL et al. Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. Circulation research 2019;124:161-169.

Hummel JP, Mayse ML, Dimmer S, Johnson PJ. Physiologic and histopathologic effects of targeted lung denervation in an animal model. Journal of applied physiology (Bethesda, Md : 1985) 2019;126:67-76.

Kumar N, Simek S, Garg N et al. Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency. Hypertension (Dallas, Tex : 1979) 2019;73:60-67.

Shea S, Stein JH, Jorgensen NW et al. Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque. Arteriosclerosis, thrombosis, and vascular biology 2019;39:89-96.

Lee JJ, Cheng SJ, Huang CY et al. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes. EBioMedicine 2019.

January CT, Wann LS, Calkins H et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation 2019:Cir0000000000000665.

Johnson HM, Sullivan-Vedder L, Kim K et al. Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trial. Contemporary clinical trials 2019;78:88-100.

Lacharite-Roberge AS, Raza F, Bashir R et al. Case series of seven women with uterine fibroids associated with venous thromboembolism and chronic thromboembolic disease. Pulmonary circulation 2019;9:2045894018803873.

McDermott MM, Polonsky TS, Guralnik JM et al. Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. Journal of the American Heart Association 2019;8:e011001.

Djamali A, Singh T, Melamed ML et al. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study. American journal of kidney diseases : the official journal of the National Kidney Foundation 2019.


Li Z, Agrawal V, Ramratnam M et al. Cardiac Sodium-Glucose Co-Transporter 1 (SGLT1) is a Novel Mediator of Ischemia/Reperfusion Injury. Cardiovascular research 2019.

Mitchell CC, Korcarz CE, Gepner AD et al. Carotid Artery Echolucency, Texture Features, and Incident Cardiovascular Disease Events: The MESA Study. Journal of the American Heart Association 2019;8:e010875.

Steffen BT, Thanassoulis G, Duprez D et al. Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 2019:Atvbaha118312267.

Kipp R, Askari M, Fan J, Field ME, Turakhia MP. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study. JACC Clinical electrophysiology 2019;5:231-241.